Navigation Links
Gonorrhea – Godzilla Of STD

Gonorrhea, the common sexually transmitted disease has evolved to become resistant to all classes of antibiotics save one, say alarmed health professionals. //

Accordingly, the U.S. Centers for Disease Control and Prevention (CDC) has said that it will no longer recommend the use of fluoroquinolones due to the emergence of drug-resistant strains in recent years that subdue them.

Yet, hope remains as there is no indication so far that the strains that cause gonorrhea have become or are becoming resistant to the remaining class of antibiotics, known as cephalosporins.

Voicing his concerns, Dr. John Douglas, director of the CDC ’s Division of Sexually Transmitted Diseases Prevention, was quoted: “Although the cephalosporins offer several potential options for treating gonorrhea, the lack of additional classes of antibiotics is a serious concern. There are currently no new drugs for gonorrhea in the drug development pipeline.”

Experts note that this form of resistant gonorrhea previously common among homosexual and bisexual men, are now seen among heterosexual men.

The CDC has released data indication that gonorrhea has become resistant to fluoroquinolones.

Douglas added:” While we have not seen any significant resistance to cephalosporins to date, any emerging resistance would be a significant public health concern. Clearly, there is an urgent need for new, effective medicines to treat gonorrhea as we are running out of options to treat this serious disease.”

The CDC recommends an injectable drug called ceftriaxone, sold by Roche Pharmaceuticals as Rocephin, to treat genital, anal and throat gonorrhea.



'"/>




Page: 1

Related medicine news :

1. Gonorrhea Found To Increase Cancer Risk
2. Gonorrhea and Male Bladder Cancer-Ties That Bound
3. Rare Gonorrhea Strain Makes Diagnosis Very Difficult
4. Scientists Concerned About Gonorrhea’s Drug Resistanc
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... June 23, 2016 Research and ... in Europe 2016 Edition: The New Global Agenda " ... OTC Distribution in Europe - ... explores and tracks change. It identifies the driving factors coming ... the consumer healthcare industry now and in the future. It ...
(Date:6/23/2016)... June 23, 2016 The ... the development of combination therapies trend is expected ... treatment of CLL were available only in the ... are chlorambucil in combination with prednisone, and a ... a growing trend of developing combination therapies to ...
Breaking Medicine Technology: